dysfunction Archives - NeuroNews International

Axonics secures US$40M financing to commercialise neuromodulation device

5 April 2018

Axonics has secured US$40 million to support commercialisation of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the...

Write to us
Editor: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: dysfunction

Axonics secures US$40M financing to commercialise neuromodulation device